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Introduction 
  
INTRODUCTION 
 
       Alcohol abuse is prevalent across all countries. The pattern of alcohol use 
varies depending on age, religion, education and other socio-demographic 
characteristics. Since 1970, consumption of alcohol in developing countries and 
developed countries have increased by 47% and 35%, respectively6 . Alcohol 
causes 4% of the total Disability Adjusted Life Years (DALYs) and alcohol  abuse 
disorders account for 1.4% of the total burden of disease7. 
 
        The prevalence of current alcohol use has been reported to be 20–38% in 
males and  10% among females8. Studies in northern India found the 1 year 
prevalence of alcohol use to be between 25 and 40%9,10 . In southern India, the 
prevalence of current alcohol use varies between 33 and 50%, with a higher 
prevalence among the lesser educated and the poor11 . These studies have shown 
that alcohol consumption rates are much higher among men than women.  
 
           Although one to two drinks per day in a healthy individual can have some 
beneficial cardiovascular effects, at higher doses alcohol is toxic to most organ 
systems. When ingested in higher amounts, ethanol may cause ventricular systolic 
and/or diastolic dysfunction, systemic arterial hypertension, arrhythmias and even 
sudden cardiac death. Excess alcohol consumption over a long period can 
progressively worsen cardiac function and cause dilated cardiomyopathy12 .As the  
disease progresses, subtle signs may be identified that precede the appearance of  
clinically evident cardiac dysfunction13 . This is significant as early abstinence may 
reverse the left ventricular dysfunction14. Numerous studies have been done on the 
effect of chronic alcohol consumption on systolic and diastolic LV function, some 
of which showed impaired 13,15 whereas others showed well preserved LV systolic 
function16-18. Normal18 and impaired LV filling19,20 has also been reported. 
 
        Hence this study was conducted to assess the systolic and diastolic function of 
the left ventricle in  asymptomatic alcoholics attending Stanley medical college 
and hospital. 
  
  
 
 
 
 
 
Aim of the Study 
  
AIM OF THE STUDY 
 
1. To assess preclinical left ventricular dysfunction in chronic asymptomatic 
alcoholics using 2 dimensional & Doppler echocardiography. 
 
2. To correlate the possible differences with the duration of alcohol intake. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Review Of Literature 
  
REVIEW OF LITERATURE 
 
 
       Alcohol is consumed at some point of time by up to 80% of the population. 
Though at low doses it can have some beneficial effects, heavy repetitive drinking 
increases the risk of health problems in many organ systems and cuts short the life 
span by an estimated decade.  
 
PHARMACOLOGY & METABOLISM 
 
       Ethanol, also called ethyl alcohol or pure alcohol, is a volatile, flammable, 
colourless liquid. It is a straight-chain alcohol, and its molecular formula is 
C2H5OH. It is a weakly charged molecule that moves easily through cell 
membranes, rapidly equilibrating between blood and tissues. 
 
       Ethanol is absorbed from mucous membranes of the mouth and esophagus in 
small amounts and from the stomach and large bowel in modest amounts. 
However, the major site of absorption is the proximal portion of the small intestine. 
The rate of absorption is increased by rapid gastric emptying; absence of 
congeners; absence of proteins, fats, or carbohydrates which interfere with 
absorption; and by dilution to a modest percentage of ethanol (maximum at ~20% 
by volume). 
       Between 2% - 10% of ethanol is excreted directly through sweat, lungs or 
urine. But the major portion is metabolized to acetaldehyde, primarily in the liver. 
The most important pathway occurs in the cell cytosol where alcohol 
dehydrogenase (ADH) produces acetaldehyde, which is then rapidly converted by 
aldehyde dehydrogenase (ALDH) to acetate and acetyl CoA in the cytosol and 
mitochondria . A second pathway occurs in the microsomes of the smooth 
endoplasmic reticulum known as the microsomal ethanol-oxidizing system 
(MEOS) which is responsible for ≥ 10% of ethanol oxidation at high blood alcohol 
concentrations.  
                 
       Alcohol supplies calories (70–100 kcal/drink) but they are devoid of minerals, 
vitamins and proteins. Alcohol interferes with absorption of nutrients like folic 
acid, pyridoxine (B6), thiamine (B1), nicotinic acid (niacin, B3) and vitamin A and 
decreases their storage in the liver.  
 
PATHOPHYSIOLOGY 
       At low or moderate doses, alcohol primarily acts as a positive allosteric 
modulator of GABAA. Alcohol binds to several different subtypes of GABAA. The 
main subtypes responsible for the subjective effects of alcohol are the α1β3γ2, 
α5β3γ2, α4β3δ and α6β3δ subtypes21,22. Activation of these receptors causes most 
of the effects of alcohol such as relaxation and relief from anxiety, sedation, ataxia 
and increase in appetite and lowering of inhibitions. 
       Alcohol has a powerful effect on glutamate as well. Alcohol decreases 
glutamate's ability to bind with NMDA receptors and acts as an antagonist of the 
NMDA receptor23,24. Hence, chronic alcohol users experience an upregulation of 
NMDA receptors because the brain is attempting to reestablish homeostasis. This 
alteration of receptor numbers is likely to be responsible for some of the symptoms 
seen in delirium tremens and alcohol withdrawal seizures. 
Other targets such as sodium channels can also be affected by high doses of 
alcohol, and alteration in the numbers of these channels in chronic alcoholics is 
likely to be responsible for effects such as cardiac arrythmia25. 
       Alcohol also affects opioid systems and cannabinol receptors, enhances 
activity of the dopamine-rich reward system and increases serotonin actions. It 
may also inhibit the uptake of adenosine. 
TOLERANCE 
       3 types of tolerance can be seen : 
(1) Metabolic or pharmacokinetic tolerance: This is seen after 1–2 weeks of daily 
drinking. There is an increase in the rate of hepatic ethanol metabolism upto 30%. 
This phenomenon disappears almost as rapidly as it develops. 
 (2) Cellular or pharmacodynamic tolerance: This develops through 
neurochemical changes that maintain relatively normal physiologic functioning 
despite the presence of alcohol. Withdrawal symptoms occur when there is a 
decrease in blood alcohol levels. 
 (3) Behavioral tolerance - Individuals learn to adapt their behavior so that they 
can function better than expected under influence of the drug. 
BEHAVIORAL EFFECTS 
       The level of alcohol in the blood is expressed as milligrams or grams of 
ethanol per deciliter with blood values of about 0.02 g/dL resulting from the 
ingestion of one typical drink. 
 
Effects of Blood Alcohol Levels in the Absence of Tolerance 
  
Blood Level (g/dL)                             Usual Effect  
 
         0.02                              Decreased inhibitions, a slight feeling of intoxication  
         0.08                              Decrease in complex cognitive functions and motor 
                                                    performance  
         0.20                              Slurred speech, motor incoordination, irritability and    
                                                     poor judgement  
         0.30                              Light coma and depressed vital signs  
         0.40                              Death  
 
ALCOHOL EQUIVALENTS 
 
      The amount of alcohol in grams of ethanol can be calculated as per the 
following conversion 26: 
        30 ml hard liquor  =  100 ml wine  =  250 ml beer  =  10 grams of ethanol 
which is usually considered as one drink. But the amount of pure ethanol in a 
standard drink varies from country to country. 
 
THE EFFECTS OF ETHANOL ON ORGAN SYSTEMS 
 
 
CARDIOVASCULAR SYSTEM 
 
 
       Although the ingestion of a moderate amount of ethanol (three to nine drinks/ 
week) appears to be associated with a reduced risk of cardiovascular disease, the 
consumption of excessive amounts has many adverse effects on the cardiovascular 
system. 
 
SYSTEMIC ARTERIAL HYPERTENSION 
 
 
       Ethanol is of etiologic importance in up to 11 percent of men with 
hypertension. Individuals who consume more than 2 drinks daily are 1.5 to 2 times 
more likely to have hypertension when compared with age- and gender-matched 
nondrinkers27. This effect is dose related and is most prominent when the daily 
ethanol intake exceeds  30 gm28 . Although the mechanism is unclear, previous 
studies have demonstrated that ethanol consumption increases plasma levels of 
catecholamines, renin, and aldosterone which result in systemic arterial 
vasoconstriction. Abstinence results in normalization of the blood pressure. 
 
LIPID METABOLISM 
       Ethanol inhibits the oxidation of free fatty acids by the liver, which stimulates 
hepatic triglyceride synthesis and the secretion of very low-density lipoprotein 
cholesterol. Hence, ethanol consumption results in hypertriglyceridemia. It also 
may increase the serum concentrations of total cholesterol and low-density 
lipoprotein (LDL). However, moderate alcohol consumption increases the serum 
concentration of high-density lipoprotein (HDL) cholesterol29. 
CORONARY ARTERY DISEASE 
       Consumption of large quantities of alcohol is associated with an increased 
incidence of atherosclerotic coronary artery disease and resultant cardiovascular 
morbidity and mortality. This  may partly be due to the fact that heavy drinkers 
compared with non-drinkers have hypertension, an increased left ventricular 
muscle mass with concomitant diastolic and/or systolic dysfunction, and 
hypertriglyceridemia. In addition, they are often smokers. 
       However, mild to moderate ethanol intake (two to seven drinks/ week) appears 
to be associated with a decreased risk of cardiovascular morbidity and mortality in 
both men and women . Several prospectively performed cohort studies have 
demonstrated that drinkers of moderate amounts of ethanol are 40 to 70 percent 
less likely to manifest coronary artery disease when compared with nondrinkers or 
heavy consumers30. A meta-analysis of all experimental studies that assessed the 
effects of moderate alcohol intake on concentrations of high density lipoprotein 
cholesterol, apolipoprotein A I, fibrinogen, triglycerides and other biological 
markers previously found to be associated with risk of coronary heart disease, has 
concluded that 30 g of alcohol a day would cause an estimated reduction of 24.7% 
in the risk of coronary heart disease through changes in lipids and haemostatic 
factors29. Some studies have suggested that the consumption of all alcoholic 
beverages exerts such an effect, whereas others have reported that this 
cardioprotection is strongest with the consumption of wine31. 
       The decrease in the cardiovascular risks is due to the beneficial effects of 
ethanol such as:  
(a) an increase in the serum concentrations of HDL cholesterol and 
apolipoprotein  A-I, 
      (b) inhibition of platelet aggregation,  
      (c) a decreased serum fibrinogen concentration,  
      (d) increased antioxidant activity (from the phenolic compounds and flavonoids      
contained in red wine), and                    
       (e) improved fibrinolysis (due to increased concentrations of endogenous 
tissue plasminogen activator and a concomitant decrease in endogenous 
plasminogen activator inhibitor activity) 
       The reduction in the risk of coronary artery disease is similar among diabetic 
and non diabetic men and women32. In survivors of myocardial infarction, 
moderate ethanol consumption appears to reduce subsequent mortality33. 
ARRYTHMIAS 
       Ethanol consumption is associated with a variety of arrhythmias like atrial or 
ventricular premature beats, supraventricular tachycardia, atrial flutter or 
fibrillation, ventricular tachycardia or fibrillation. The most common arrhythmia is 
atrial fibrillation. Ethanol is of etiologic importance in about one third of subjects 
with new-onset atrial fibrillation. Most episodes occur after binge drinking, usually 
on weekends or holidays—known as the “holiday heart syndrome.”   
       Ethanol may be arrhythmogenic via several mechanisms. Concomitant factors 
like cigarette smoking, electrolyte disturbances, metabolic abnormalities, 
hypertension or sleep apnea may predispose to arrhythmias. Acute ethanol 
ingestion induces a diuresis, which is accompanied by urinary loss of sodium, 
potassium, and magnesium resulting in an electrolyte imbalance. The presence of 
myocardial interstitial fibrosis, ventricular hypertrophy, cardiomyopathy, and 
autonomic dysfunction also may enhance the likelihood of dysrhythmias. The 
treatment of these arrhythmias is abstinence from alcohol. 
ALCOHOLIC CARDIOMYOPATHY 
       Alcoholic cardiomyopathy is a clinical diagnosis made in a patient presenting 
with a constellation of findings that includes a history of excessive alcohol intake, 
possible physical signs of alcohol abuse, heart failure, and supportive evidence 
consistent with dilated cardiomyopathy. 
EFFECTS OF ETHANOL ON CARDIAC MYOCYTE STRUCTURE AND 
FUNCTION 
       Ethanol may cause myocardial damage via several mechanisms34. Ethanol and 
its metabolites, acetaldehyde and acetate, may exert a direct toxic effect on the 
myocardium or deficiencies of certain vitamins, minerals or electrolytes may 
adversely affect myocardial function. Sometimes, certain toxic substances like lead 
or cobalt are added to alcoholic beverages which may be toxic to the myocardium. 
Mechanisms of ethanol induced myocardial injury2: 
 
       Direct Toxic Effects  
      Uncoupling of the excitation/contraction system  
      Reduced calcium sequestration in sarcoplasmic reticulum  
     Inhibition of sarcolemmal ATP-dependent Na +/K+     pump  
     Reduction in mitochondrial respiratory ratio  
     Altered substrate utilization  
     Increased interstitial/extracellular protein synthesis  
 
    Toxic Effect of Metabolites
    Acetaldehyde  
    Ethyl esters  
 
    Nutritional or Trace Metal Deficiencies
    Thiamine  
    Selenium  
 
    Electrolyte Disturbances
    Hypomagnesemia  
    Hypokalemia  
    Hypophosphatemia  
 
    Toxic Additives  
    Cobalt  
    Lead  
 
       Electron microscopic studies of the hearts of experimental animals with heavy 
ethanol ingestion demonstrate dilated sarcoplasmic reticula and swollen 
mitochondria with fragmented cristae and glycogen-filled vacuoles. With sustained 
exposure to ethanol, myofibrillar degeneration and replacement fibrosis appear. 
Microscopically, the hearts of chronic heavy consumers of ethanol manifest an 
increased accumulation of collagen in the extracellular matrix, as well as increased 
intermolecular cross-links. 
EFFECTS ON CARDIAC FUNCTION 
       Chronic heavy ethanol ingestion may induce left ventricular diastolic and/or 
systolic dysfunction. Diastolic dysfunction which is partly due to interstitial 
fibrosis of the myocardium, is often demonstrable in chronic alcoholics even in the 
absence of symptoms or signs. About half of asymptomatic chronic alcoholics 
have echocardiographic evidence of left ventricular hypertrophy with preserved 
systolic performance. By Doppler echocardiography, the left ventricular relaxation 
time is often prolonged, the peak early diastolic velocity is reduced, and the 
acceleration of early diastolic flow is slowed which indicate left ventricular 
diastolic dysfunction20,35.  
       Around 30 percent of asymptomatic chronic alcoholics have evidence of left 
ventricular systolic dysfunction in echocardiography. With continued heavy 
ethanol ingestion, these subjects often develop dilated cardiomyopathy that 
manifests clinically as congestive cardiac failure. Ethanol abuse is the most 
common cause of non ischemic dilated cardiomyopathy. Women are more 
susceptible compared to males as they develop cardiomyopathy following 
ingestion of lesser quantities of ethanol36.  
       Left ventricular systolic and diastolic function often improve following 
abstinence from alcohol37; these changes are more pronounced when abstinence is 
initiated early in the course of ethanol consumption.  
       There are individual variations in the susceptibility to ethanol's cardiotoxic 
effects. In this regard, some studies have suggested that genetic polymorphisms in 
the angiotensin-converting enzyme (ACE) gene may play a role in the 
development of ethanol-induced dilated cardiomyopathy. Subjects who are 
homozygous for the deletion polymorphism of the ACE gene (so-called DD) have 
increased plasma and cardiac levels of ACE. In the absence of ethanol 
consumption, these homozygotes are at increased risk of developing left 
ventricular hypertrophy and idiopathic dilated cardiomyopathy. Similarly, 
alcoholics who are homozygous for this deletion polymorphism are more likely to 
develop a dilated cardiomyopathy than alcoholic subjects without it38. Likewise, a 
polymorphism of the gene encoding the alcohol metabolizing enzyme, alcohol 
dehydrogenase (ALDH2*2) increases the predilection for the development of 
alcoholic cardiomyopathy 
QUANTITY OF ALCOHOL INTAKE IN CARDIAC DISEASE 
       The likelihood of developing an ethanol-induced dilated cardiomyopathy 
correlates with the amount of ethanol that is consumed in a lifetime. Most men 
who develop an ethanol-induced dilated cardiomyopathy have consumed more 
than 80 gm of ethanol  per day for at least 5 years.A study by Urbano-Marquez et 
al15 reported on 48 men with alcohol abuse with a mean daily intake of 243 g of 
alcohol and showed (1) an inverse relationship between total lifetime intake and 
ejection fraction and fractional shortening and (2) a direct relationship between 
total lifetime intake and LV mass. In persons who consumed 70 g of ethanol  per 
day for 20 years, 36% had an abnormal ejection fraction.  
DURATION OF ALCOHOL INTAKE IN CARDIAC DISEASE 
       Similarly, the likelihood of developing cardiomyopathy correlates with the 
duration of alcohol intake. A study by Lazarevic et al39 demonstrated that the 
progression of left ventricular diastolic dysfunction was related to the duration of 
alcoholism. 
 
EPIDEMIOLOGY 
Sex related demographics 
       Although alcoholic cardiomyopathy is a disease that affects males more often 
than females due to a higher rate of alcohol abuse in men, females may be more 
susceptible to alcohol's cardiotoxic effects. 
       In 1995, Urbano-Marquez et al36 described similar results in a study of 50 
women and 100 men who abused alcohol. The authors reported a lifetime dose of 
alcohol in the female group that was 60% of that in the male group, but they found 
an equal incidence of cardiomyopathy in the males and females. 
Age related demographics 
       Middle aged persons are most commonly affected and incidence is less in 
those younger than 40 years, although preclinical cardiac abnormalities have been 
demonstrated in young persons20 engaging in chronic alcohol abuse.  
CLINICAL FEATURES 
       Alcoholic cardiomyopathy similar to any dilated cardiomyopathy manifests as 
congestive cardiac failure.  Dyspnoea, orthopnoea, and paroxysmal nocturnal 
dyspnoea are the hallmark complaints. Other symptoms like chest discomfort, 
fatigue, palpitations, dizziness, syncope, anorexia may also be present. The onset 
of symptoms is usually insidious, but atrial fibrillation or any other 
tachyarrhythmia may precipitate acute decompensations. 
       On examination, the apical impulse may be displaced laterally implying 
cardiomegaly. Auscultation may reveal S3, S4, murmurs of mitral or tricuspid 
regurgitation. Pulmonary rales indicate pulmonary congestion secondary to 
elevated left heart pressures. Jugular venous distention, peripheral edema, and 
hepatomegaly are evidence of elevated right heart pressures. 
       However, before an individual manifests features of congestive cardiac failure, 
certain changes occur in the heart in the preclinical stage which is asymptomatic. 
There may be evidence of diastolic and/or systolic dysfunction which can only be 
picked up by echocardiography. 
INVESTIGATIONS 
Lab -  Alcoholics may show an increase in mean corpuscular volume, aspartate 
aminotransferase and gamma glutamyl transferase. 
Electrocardiogram– the following abnormalities may be seen : atrial fibrillation, 
flutter  and premature contractions; conduction disturbances, such as degrees of 
atrioventricular block, right or left bundle-branch block, and hemiblocks; 
prolonged QT interval; LV hypertrophy;nonspecific ST- and T-wave changes and 
Q waves.  
Imaging - Chest radiographs usually show evidence of cardiac enlargement, 
pulmonary congestion, and pleural effusions.  
 
Echocardiography : 
       Echocardiographic findings in persons with alcoholic cardiomyopathy, which 
are similar to those in persons with idiopathic dilated cardiomyopathy, are as 
follows: 
 4-chamber dilatation 
 Globally decreased ventricular function 
 Mitral and tricuspid regurgitation 
 Pulmonary hypertension 
 Evidence of diastolic dysfunction by Doppler  
 Intracardiac thrombi (atrial or ventricular) 
 LV hypertrophy 
       In the asymptomatic stage, echocardiography may show evidence of systolic 
and/ diastolic dysfunction. 2-D, M-mode and Doppler echocardiography are used. 
The following changes have been documented by numerous studies15,19,39: 
 Increased chamber volumes (end systolic & end diastolic) 
 Normal/reduced ejection fraction 
 Increased left ventricular mass 
 Increased LV posterior wall & interventricular septal thickness 
 Diastolic dysfunction :  prolonged isovolumic relaxation time 
                                       Increased deceleration time 
                                       Reduced E/A ratio 
PROGNOSIS 
       The natural history of patients with alcoholic cardiomyopathy depends on each 
patient's ability to abstain from alcohol completely. Multiple case reports and small 
retrospective and prospective studies have clearly documented marked 
improvement or normalization of cardiac function with abstinence37.  
MANAGEMENT 
       The mainstay of therapy for alcoholic cardiomyopathy is complete abstinence 
from alcohol. 
       Medical therapy for symptomatic patients is identical to conventional therapy 
for other forms of heart failure. This includes treatment with an ACE inhibitors, 
digoxin, diuretics, beta blockers. Electrolyte abnormalities should be corrected 
promptly because of the risk of arrhythmia and sudden death. Anticoagulation 
should be initiated only after weighing the risks versus benefits.  Thiamine (200 
mg once daily), vitamin supplements,  folic acid, and mineral supplementation are 
beneficial because of the significant prevalence of concomitant nutritional 
deficiencies in these patients. 
 
NERVOUS SYSTEM 
       Around 35% of alcoholics experience a blackout, an episode of temporary 
anterograde amnesia, in which the person cannot recall what occurred during a 
drinking evening. Heavy drinking can also be associated with a hangover 
syndrome the following day characterized by thirst, nausea, vomiting, headache 
and fatigue. 
       Sleep disturbances are common. Although alcohol might initially help a 
person to fall asleep, it disrupts sleep throughout the rest of the night. The stages of 
sleep are also altered, and time spent in rapid eye movement (REM) and deep sleep 
is reduced. Disturbing dreams are frequently experienced. Alcohol can cause 
snoring and exacerbate sleep apnea as it relaxes muscles in the pharynx. 
       Chronic high doses cause peripheral neuropathy in 5–15% of alcoholics. 
Symptoms are bilateral limb numbness, tingling, and paresthesias  which are more 
prominent distally. Approximately 1% of alcoholics develop cerebellar 
degeneration or atrophy characterized clinically by nystagmus, unsteadiness and 
ataxia. Atrophy of the cerebellar vermis can be confirmed by neuroimaging. 
Rarely, in predisposed individuals (e.g.  transketolase deficiency) thiamine 
deficiency may result in Wernicke's (ophthalmoparesis, ataxia, and 
encephalopathy) and Korsakoff's (retrograde and anterograde amnesia) syndromes.  
       Alcoholics can manifest cognitive problems lasting for weeks to months after 
an alcoholic binge. Many psychiatric syndromes can be seen temporarily during 
heavy drinking and subsequent withdrawal. These include an profound sadness 
lasting for days to weeks in the midst of heavy drinking  (alcohol-induced mood 
disorder); temporary severe anxiety that often begins during alcohol withdrawal, 
and which can persist for a month or more after cessation of drinking (alcohol-
induced anxiety disorder); and auditory hallucinations and/or paranoid delusions in 
a person who is alert and oriented (alcohol-induced psychotic disorder). 
       Studies have demonstrated that moderate alcohol consumption upto two drinks 
per day was significantly protective for ischemic stroke40. 
       Once the brain has been repeatedly exposed to high doses of alcohol, any 
sudden decrease in intake can produce withdrawal symptoms like hand tremors, 
anxiety, agitation, tachycardia, tachypnea, fever, insomnia. These withdrawal 
symptoms generally begin within 5–10 h of decreasing ethanol intake, peak on the 
2nd or 3rd day and improve by 4th or 5th day. A small percentage of alcoholics 
experience withdrawal seizures usually manifesting as a single generalized 
seizure.Very rarely, in alcohol dependent individuals, acute withdrawal may result 
in delirium (agitation, confusion and fluctuating levels of consciousness) 
associated with a tremor and autonomic overactivity known as delirium tremens. 
 
THE GASTROINTESTINAL SYSTEM 
       Alcohol intake can result in esophagitis and gastritis which may manifest as 
gastrointestinal bleeding. A longitudinal tear in the mucosa at the gastroesophageal 
junction can be produced by violent retching or vomiting which is known as 
Mallory-Weiss lesion. 
       Acute pancreatitis is three times more common in alcoholics. There is a higher 
incidence of fatty liver because of impaired gluconeogenesis in the liver, resulting 
in a decrease in the amount of glucose produced from glycogen, increased lactate 
production, and decreased oxidation of fatty acids. These changes are reversible 
with abstinence but continued alcohol intake may lead to alcoholic hepatitis and 
later on, cirrhosis. 
 HAEMATOPOEITIC SYSTEM 
       Ethanol causes an increase in mean corpuscular volume of red blood cells due 
to its effects on stem cells. Concomitant folic acid deficiency manifests as 
hypersegmented neutrophils, decreased reticulocyte counts and a hyperplastic bone 
marrow. Chronic heavy drinking can decrease production of white blood cells, 
decrease granulocyte mobility and adherence, and impair delayed-hypersensitivity 
responses to novel antigens.  
MALIGNANCIES 
       Alcohol increases the risk of the following cancers: mouth, pharynx and 
larynx, oesophagus, colorectum (men), breast (pre- and postmenopausal women). 
This is postulated to be due to the toxic effects of acetaldehyde, the breakdown 
product of ethanol metabolism. 
REPRODUCTIVE SYSTEM 
       In males, consumption of modest doses of ethanol may increase sexual drive 
but they reduce the erectile capacity. Even in the absence of liver impairment, a 
minor percentage of chronic alcoholic men show irreversible testicular atrophy 
with shrinkage of the seminiferous tubules, decrease in ejaculate volume and a 
lower sperm count. 
       Chronic alcohol consumption in females can result in amenorrhea, a decrease 
in ovarian size, absence of corpora lutea with associated infertility and an increased 
risk of spontaneous abortion. Ethanol and acetaldehyde are transferred across the 
placental barrier which may result in fetal alcohol syndrome characterized by: 
facial abnormalities with epicanthal eye folds; poorly formed ear concha; small 
teeth with faulty enamel; atrial or ventricular septal defects; an aberrant palmar 
crease and limitation in joint movement; and microcephaly with mental retardation.  
MUSCULOSKELETAL SYSTEM 
       Around 50 to 65 % manifest acute alcoholic myopathy, which is characterized 
by skeletal muscle weakness which may improve with abstinence, but some 
residual weakness usually remains. Chronic consumption of alcohol affects the 
skeletal system by altering calcium metabolism, reducing growth in the epiphyses 
and decreasing the bone density that results in increased risk for fractures.  
ENDOCRINE SYSTEM 
       Hormonal changes include a reduction in the levels of serum thyroxine (T4) 
and triiodothyronine (T3) and an increase in cortisol levels. There is inhibition of 
vasopressin secretion at high blood alcohol concentrations and enhanced secretion 
at low blood alcohol concentrations. Hormone irregularities should be re evaluated 
after a month of abstinence. 
 
ALCOHOLISM 
       Alcoholism is a common problem worldwide. A recent National Household 
Survey of Drug Use in India41  recorded alcohol use in the past year in 21% of 
adult males. The prevalence of current use of alcohol ranged from a low of 7% in 
the western states to 75% in the North-eastern states. Prevalence among women 
has been estimated at less than 5% but is much higher in the North-eastern states. 
Significantly higher use has been recorded among tribal, rural and lower socio-
economic urban sections. 
       When repeated problems in multiple spheres of life develop due to alcohol 
consumption, the individual is likely to meet criteria for alcohol abuse or 
dependence. Worldwide, the diagnostic criteria for alcohol abuse and dependence 
of two institutions, the World Health Organization (WHO) and the American 
Psychiatric Association (APA) are the most widely accepted. The WHO issues the 
International Classification of Diseases (ICD) and the APA issues the Diagnostic 
and Statistical Manual of Mental Disorders (DSM). Both institutions regularly 
update their classification systems. ICD is in its 10th version (ICD-10) and DSM in 
its 4th (DSM-IV). 
Definitions 
DSM-IV42 
ALCOHOL ABUSE 
1. A maladaptive pattern of alcohol abuse leading to clinically significant 
impairment or distress, as manifested by one or more of the following, 
occurring within a 12-month period:  
o Recurrent alcohol use resulting in failure to fulfil major role 
obligations at work or home (e.g., repeated absences or poor work 
performance related to substance use; substance-related absences; or 
neglect of children or household).  
o Recurrent alcohol use in situations in which it is physically hazardous 
(e.g., driving an automobile or operating a machine).  
o Recurrent alcohol-related legal problems (e.g., arrests for alcohol-
related disorderly conduct).  
o Continued alcohol use despite persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the 
alcohol (e.g., arguments with spouse about consequences of 
intoxication or physical fights).  
2. These symptoms must never have met the criteria for alcohol dependence. 
ALCOHOL DEPENDENCE 
       A maladaptive pattern of alcohol use, leading to clinically significant 
impairment or distress, as manifested by three or more of the following seven 
criteria, occurring at any time in the same 12-month period:  
1. Tolerance, as defined by either of the following:  
o A need for markedly increased amounts of alcohol to achieve 
intoxication or desired effect. 
o Markedly diminished effect with continued use of the same amount of 
alcohol. 
2. Withdrawal, as defined by either of the following:  
o The characteristic withdrawal syndrome for alcohol  
o Alcohol is taken to relieve or avoid withdrawal symptoms.  
3. Alcohol is often taken in larger amounts or over a longer period than was 
intended.  
4. There is a persistent desire or there are unsuccessful efforts to cut down or 
control alcohol use.  
5. A great deal of time is spent in activities necessary to obtain alcohol, use 
alcohol or recover from its effects.  
6. Important social, occupational, or recreational activities are given up or 
reduced because of alcohol use.  
7. Alcohol use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been 
caused or exacerbated by the alcohol (e.g., continued drinking despite 
recognition that an ulcer was made worse by alcohol consumption).  
  
ICD – 1045 
F 10 Mental and behavioural disorders due to the use of alcohol 
The following fourth-character subdivisions are for use: 
       .0 Acute intoxication 
       .1 Harmful use 
       .2 Dependence syndrome 
       .3 Withdrawal state 
       .4 Withdrawal state with delirium 
       .5 Psychotic disorder 
       .6 Amnesic syndrome 
       .7 Residual and late onset psychotic disorder 
       .8 Other mental and behavioural disorders 
       .9 Unspecified mental and behavioural disorders 
 
GENETICS OF ALCOHOLISM 
       Several separate and distinct characteristics appear to contribute to the risk of 
alcoholism. Some families are at risk for both alcoholism and drug dependence 
associated with the characteristic of high levels of impulsivity, as can be seen in 
the antisocial personality disorder. In other families, the risk for both alcohol and 
drug dependence may relate to a genetic vulnerability to schizophrenia, panic 
disorder, or manic depressive disease. In certain other families, there is an 
increased risk for alcoholism alone due to a low response to alcohol and 
subsequently drinking higher doses to achieve the desired effects. In contrast, a 
decreased risk for heavy drinking can result from a mutation that causes the 
production of an inactive form of the enzyme aldehyde dehydrogenase. This results 
in a more intense response to alcohol due to higher levels of acetaldehyde 
following alcohol ingestion. 
IDENTIFICATION OF THE ALCOHOLIC 
       The clinical diagnosis of alcohol abuse or dependence ultimately rests on the 
documentation of a pattern of repeated difficulties associated with alcohol use; the 
definition is not based on the quantity and frequency of alcohol consumption. 
       Physical signs and symptoms that can be useful in identifying alcoholism 
include mild and fluctuating hypertension, repeated infections such as pneumonia 
and otherwise unexplained cardiac arrhythmias. Other disorders suggestive of 
dependence include cirrhosis, unexplained hepatitis, pancreatitis, bilateral parotid 
gland swelling, peripheral neuropathy and malignancies of the head and neck, 
esophagus or stomach. 
        Laboratory tests that are likely to be abnormal in individuals consuming more 
than 6 drinks/day are gamma-glutamyl transferase (GGT) (>35 U) and 
carbohydrate-deficient transferrin (CDT) (>20 U/L). The sensitivity and specificity 
is ≥ 70%. The combination of both the tests is likely to be more accurate. These 
serologic markers can also be useful in monitoring abstinence, as they are likely to 
return toward normal within several weeks of the cessation of drinking. Other 
investigations that are abnormal are high-normal MCVs (≥91μ m3) and serum uric 
acid (>7 mg/dL).  
       Disorders related to the use of alcohol are common in general hospitals and are 
associated with higher morbidity and mortality. However, between 37% and 49% 
of the patients suffering from alcohol-related disorders and admitted to general 
hospitals due to physical illnesses are not identified as such. This is partially due to 
time constraints, fear of discrimination and lack of awareness of the importance of 
the diagnosis on the part of the patient and the attending physician. Therefore,to 
facilitate the screening of such patients, diagnostic instruments that are brief, 
simple, easy to apply and unintimidating like CAGE and AUDIT have been 
developed. 
CAGE  
       A clinically helpful approach to diagnosis of alcohol dependence and abuse is 
the use of the CAGE questionnaire: 
 
 
Acronym Question  
C Have you ever felt you ought to Cut down on your drinking?  
A Have people Annoyed you by criticizing your drinking?  
G Have you ever felt Guilty or bad about your drinking?  
E Have you ever had a drink first thing in the morning to steady your 
nerves or get rid of a hangover (Eyeopener)?  
 
 
 
One "yes" response should raise suspicion of an alcohol use problem, and more 
than one is a strong indication that abuse or dependence exists. 
 
       A study by Castells MA et al44 showed that the CAGE questionnaire presented 
its highest sensitivity (93.8%) when the cut-off point of 0/1 (one or more 
“positive” responses indicating a positive test) was used. The specificity for this 
cut-off point was 85.5%.  
 
       Another study by Malet et al45 concluded that The CAGE questionnaire for a 
cut-off of 2 had a sensitivity of 77% and a specificity of 94%. The CAGE test was 
more sensitive for patients diagnosed as alcohol-dependent than for alcohol 
abusers (61% vs. 84%) with the same specificity (94%). The eye-opening question 
(E) differentiated sharply between abuse and dependency, with sensitivities of 18% 
and 46%, respectively.  
 AUDIT 
       The AUDIT ( Alcohol Use Disorders Identification Test)48 was developed by 
the WHO as a simple method of screening for excessive drinking and to assist in 
brief assessment.  
 
The AUDIT helps the practitioner  to identify whether the person has hazardous (or 
risky) drinking, harmful drinking or alcohol dependence. 
 
Hazardous drinking is a pattern of alcohol consumption that increases the risk of 
harmful consequences for the user or others.  
 
Harmful use refers to alcohol consumption that results in consequences to physical 
and mental health. Some also consider social consequences among the harms 
caused by alcohol. 
 
Alcohol dependence is a cluster of behavioural, cognitive, and physiological 
phenomena that may develop after repeated alcohol use.  
 
       The AUDIT was developed and evaluated over a period of two decades and it 
has been found to provide an accurate measure of risk across gender, age and 
cultures. It is consistent with ICD-10 definitions of alcohol dependence and 
harmful alcohol use. 
 
AUDIT Questionnaire 
 
1.How often do you have a drink containing alcohol?  Never (0) to 4+ per week (4)  
2. How many drinks containing alcohol do you have on a typical day?  
                                                                                    1 or 2 (0) to 10+ (4)  
3.How often do you have six or more drinks on one occasion?  
                                                               Never (0) to daily or almost daily (4)  
4. How often during the last year have you found that you were not able to stop 
drinking once you had started?                        Never (0) to daily or almost daily (4)  
5. How often during the last year have you failed to do what was normally 
expected from you because of drinking?         Never (0) to daily or almost daily (4)  
6. How often during the last year have you needed a first drink in the morning to 
get yourself going after a heavy drinking session?       
                                                                         Never (0) to daily or almost daily (4)  
7. How often during the last year have you had a feeling of guilt or remorse after 
drinking?                                                         Never (0) to daily or almost daily (4)  
8. How often during the last year have you been unable to remember what 
happened the night before because you had been drinking?  
                                                                        Never (0) to daily or almost daily (4)  
9. Have you or someone else been injured as a result of your drinking?  
                                                                        No (0) to yes, during the last year (4)  
10. Has a relative, friend, doctor or other health worker been concerned about your 
drinking or suggested that you should cut down? 
                                                              No (0) to yes, during the last year (4) 
       Scores for each question range from 0 to 4 with the first response for each 
question being zero, the second scoring 1 and so on. For questions 9 and 10 the 
scoring is 0,2,4. 
Interpretation :      ≥ 8  -    harmful / hazardous drinking 
                              ≥ 13 in women  
                              ≥ 15 in men  
 
  
Alcohol dependence 
ASSESSMENT OF CARDIAC FUNCTION3-5 
       Echocardiography is an excellent tool for noninvasive assessment of the left 
ventricle. 
SYSTOLIC FUNCTION 
       Echocardiography can measure several parameters as an expression of systolic 
function of the heart.  
       Measurements of the left ventricular cavity dimension and wall thickness can 
be readily derived from M-mode recordings (figure 1) in parasternal long axis view 
at the level of mitral valves and are usually made according to the 
recommendations of the American Society of Echocardiography (ASE) at end 
diastole (the onset of the QRS complex) and end systole (the point of maximum 
upward motion of the LV posterior wall endocardium)47. 
       Cardiac chamber volumes (end systolic and end diastolic) and ejection fraction 
are measured by 2-dimensional echocardiography (figure 2). Left ventricular 
volumes is calculated based on Simpson’s rule, which derives measurements by 
dividing the LV by parallel planes into a number of small segments and then 
summating the area of the individual disks. 
LV MASS 
Is calculated using the formula: 
LV mass (grams) =  0.8 { 1.04 [ (LVID + IVST + PWT)3 – LVID3 ] } + 0.6 
Where   LVIDd – left ventricular internal diameter in diastole (cm) 
              IVSTd – interventricular septal thickness in diastole (cm) 
              PWTd – posterior wall thickness in diastole (cm) 
 
DIASTOLIC FUNCTION 
       Doppler echocardiography is used for evaluation of ventricular diastolic 
filling. The transmitral velocity curves reflect the relative pressure gradients 
between the left atrium and ventricle throughout diastole. They are influenced by 
the rate of ventricular relaxation, the driving force across the valve, and the 
compliance of the ventricle. Doppler recordings of transmitral flow velocities are 
recorded at the level of leaflet tips in apical four chamber view. 
       Figure 3 illustrates the left ventricular inflow velocities and measurements for 
assessing the diastolic function of the left ventricle. Figure 3(A) shows the normal 
situation. The early inflow of blood reaches a peak at the E point. Flow then 
decelerates until atrial systole, at which time the left atrial pressure rises above the 
left ventricular pressure and flow again passes through the mitral valve.  
 
       Alterations in left ventricular diastolic function may reduce the height of the E 
wave and increase the height of the ‘A’ wave. This type of abnormality is usually 
accompanied by prolongation of the isovolumic relaxation time (IVRT) and 
prolongation of the decelaration time (DT). [Figure 3 (B)] The hemodynamic 
abnormalities responsible for this pattern usually are reduced left ventricular 
relaxation and slower fall in left ventricular pressure. 
 
       The other pathologic pattern that is seen with mitral flow velocities is the 
reverse – a tall E wave and a short A wave. This pattern is accompanied by short 
isovolumic relaxation and deceleration times. [Figure 3 (D)] This type of mitral 
inflow can be produced by elevated left ventricular filling pressures. With elevated 
early diastolic pressure, the flow into the left ventricle is accelerated and there may 
be relatively little blood to propel with atrial systole. 
 
       In some disease states, the initial pathologic pattern in abnormal relaxation 
with a short E wave and tall A wave. If mitral regurgitation or congestive heart 
failure raises the left ventricular filling pressure, then the pattern may reverse and 
the E wave will become taller and A wave will become shorter. Thus a transition 
situation can occur whereby ‘pseudonormalisation’ of the mitral inflow can occur. 
[Figure 3 (C)]. 
 
  
 
 
 
 
 
 
 
Materials and Methods 
  
MATERIALS AND METHODS 
 
1. Type of Study                         :    Observational Study 
2. Place                                        :    Stanley medical college and hospital,   
                                                           Chennai. 
3. Collaborating Departments  :    Department of Cardiology. 
4. Duration of Study                  :    April 2011 to September 2011 
5. Ethical clearance                   :    Ethical clearance was obtained and the 
                                                          study was initiated 
6. Consent                                   :    Informed consent was obtained before  
                                                          taking up the case for study 
7. Inclusion Criteria:  
            50 alcoholics attending medicine department who satisfied the following 
criteria were enrolled in the study 
 Positive diagnostic criteria for alcohol abuse or dependence as established by 
DSM IV criteria 
 Age ≤ 60 years 
 Daily ethanol consumption  ≥  90 grams  ≥ 4 days/week 
 Drinking history  ≥ 5 years 
 No history of any systemic diseases 
 
8.Exclusion criteria : 
 
 Ischemic/ rheumatic/ congenital heart disease 
 Diabetes mellitus 
 Hypertension 
 Hyperlipidemia 
 Thyroid disorders 
 
9. Methods 
 
        The alcoholics who satisfied the criteria for alcohol abuse or dependence 
according to DSM IV criteria42  were selected. 
 
       A detailed history regarding the duration and amount of alcohol consumption 
was obtained. The amount of alcohol consumed was then converted to grams of 
ethanol as per the following conversions26 : 
 
      Alcohol equivalents: 
                  30 ml spirits  =  100 ml wine  =  250 ml beer  =  10 grams of ethanol 
 
       The alcoholics were then divided into three groups as follows, based on the 
duration of alcohol consumption, in order to evaluate possible differences in the 
left ventricular function in relation to the duration of drinking. 
 
             Group 1 (Short)                :   5 – 9 years 
             Group 2 (Intermediate)    : 10 – 15 years 
             Group 3 (Long)                : > 15 years 
 
      A history of diabetes, hypertension, ischemic heart disease, rheumatic heart 
disease, hyperlipidemia, thyroid disorders and any other systemic disease were 
ruled out. 
 
       General physical examination, vital signs and systemic examination was done. 
Height and weight were obtained in order to calculate body surface area using   
MOSTELLER’S FORMULA : 
       BSA (m²) = ( [Height(cm) x Weight(kg) ]/ 3600 )½   
The following investigations were done : 
 Complete blood count 
 Renal function tests 
 Fasting and postprandial blood sugar 
 Fasting lipid profile 
 Thyroid function tests 
 Liver function tests 
 Electrocardiogram 
 Chest x ray 
 Echocardiography  
 
ECHOCARDIOGRAPHY  
            Echocardiography was done using Mylab Easovite and Aloka systems. 
     The parameters studied using 2 dimensional, M –mode and Doppler 
echocardiograph were : 
 
 Left ventricular internal dimension in diastole (LVIDd) 
 End diastolic volume (EDV) 
 End systolic volume (ESV) 
 Interventricular septal thickness in diastole (IVSTd) 
 Left ventricular posterior wall thickness in diastole (PWTd) 
 Ejection Fraction  (EF) 
 Left ventricular mass 
 Isovolumic relaxation time (IVRT) 
 Deceleration time (DT) 
 Transmitral E and A velocities 
 E/A ratio 
       The end systolic and diastolic volumes; and LV mass were converted to 
indices by dividing by body surface area. 
 
10. Statistical analysis 
          Computer analysis of the data was done using SPSS Version 19 software. 
The range, mean and standard deviations were calculated. Analysis of variance 
was used to compare the differences among the means of alcoholics and 
controls. The three alcoholic groups were compared individually with the 
controls by unpaired t – test. Stepwise multiple linear regression analysis was 
used to evaluate the effects of several independent variables on the 
echocardiographic parameters in alcoholics. Significance was established at      
p < 0.05. 
 
  
 
 
 
 
 
 
 
Observations and Results 
  
OBSERVATIONS AND RESULTS 
 
 
   The results of the present study are presented in the ensuing pages. 
 
Table 1 :  PATIENT’S CHARACTERISTICS 
 Controls Group 1 Group 2 Group 3 
 n = 50 n = 18 (36%) n = 19 (38%) n = 13 (26%) 
Age  (years) 39.26 ± 8.98 33.33 ± 6.98 38.26 ± 3.62 50.15 ± 4.99 
Smokers 24 (48%) 11 (61%) 8 (42%) 7 (53%) 
Duration of 
drinking (yrs) - 7.80 ± 1.07 11.47 ± 1.22 19.04 ± 2.31 
Ethanol 
consumption 
(g/day) 
- 114.44 ± 27.70 123.16 ± 18.27 190 ± 38.08 
Height (cm) 165.42 ± 6.22 166.06 ± 6.45 164 ± 7.09 167.30 ± 7.75 
Weight (kg) 67.82 ± 9.46 67.39 ± 11.84 78.11 ± 7.48 77.62 ± 15.33 
BSA (m2) 1.76 ±0.15 1.76 ± 0.18 1.79 ± 0.17 1.89 ± 0.22 
Pulse rate 
(beats/min) 79.16 ± 7.14 81.67 ± 6.95 79.53 ± 8.49 81.15 ± 5.55 
Systolic BP  
(mm Hg) 122.24 ± 6.83 124.56 ± 5.81 124 ± 7.09 123.54 ± 5.95 
Diastolic BP 
(mm Hg) 77.52 ± 5.56 78 ± 3.88 78.11 ± 5.48 76.77 ± 5.20 
 
       The data are presented as mean ± SD or percentage of patients. The baseline 
characteristics of controls and alcoholics were comparable. 
Table 2 :  LABORATORY DATA 
 
 Controls Group 1 Group 2 Group 3 
Hb (g/dL) 12.73 ± 0.51 12.63 ± 0.60 12.42 ± 0.53 12.89 ± 0.60 
AST (U/L) 26.34 ± 6.15 52.78 ± 15.13 66.89 ± 15.94 89.15 ± 14.25 
ALT (U/L) 27.02 ± 6.48 45.50 ± 12.45 58.32 ± 15.52 49.38 ± 28.04 
GGT (U/L) 27.32 ± 7.83 63.55 ± 10.94 67 ± 12.80 84.15 ± 14.32 
T.Bilirubin 
(mg/dL) 0.80 ± 0.21 0.84 ± 0.22 0.87 ± 0.15 0.82 ± 0.12 
T.Cholesterol 
(mg/dL) 165.24 ± 13.43 165 ± 18.85 153.26 ± 18.01 163.77 ± 20.67
TGL (mg/dL) 126.90 ± 9.85 125.89 ± 9.63 118.74 ± 16.22 121.69 ± 10.96
 
                      The data are presented as mean ± SD. 
   The labaratory parameters were similar in controls and cases except that 
alcoholics showed elevations in liver enzymes (AST, ALT, GGT) which was 
significant :      
AST p = 0.000 
ALT p = 0.027 
GGT p = 0.000 
       The echocardiographic changes in alcoholics compared to controls are 
presented in the following pages : 
 
2-D AND M-MODE ECHOCARDIOGRAPHIC MEASUREMENTS 
 
Table 3 : EDVI & ESVI  
       The end diastolic and end systolic volume indices of controls and alcoholics 
are presented below : 
  Range Mean Std. Deviation 
 
EDVI 
(mL/m2) 
Controls 34.55 – 60.38 47.04 5.73 
p = 0.000 Group 1 40.12 – 56.77 47.43 4.78 
Group 2 46.03 – 61.53 51.50 4.53 
Group 3 48.56 – 65.43 54.86 4.91 
ESVI 
(mL/m2) 
Controls 11.11 – 18.86 14.18 1.69 
p = 0.899 Group 1 11.11 – 17.03 14.29 1.59 
Group 2 11.73 – 18.86 14.30 1.75 
Group 3 11.17 – 16.27 13.87 1.83 
    
        The mean end diastolic volume index was significantly higher in alcoholics 
(p<0.001) compared to controls.  
 
Table 4 :  EJECTION FRACTION & LEFT VENTRICULAR MASS INDEX 
 
  Range Mean Std. Deviation  
EF (%) 
Controls 64 - 86 74.04 5.75 
p = 0.688 
Group 1 65 - 81 74.44 4.68 
Group 2 67 - 87 75.68 5.66 
Group 3 67 - 85 75.31 5.39 
LVMI 
(g/m2) 
Controls 53.10 – 101.92 75.73 10.66 
p = 0.000 
Group 1 63.30 – 85.45 75.07 7.18 
Group 2 66.57 – 95.43 81.93 7.55 
Group 3 81.63 – 104.50 94.44 6.95 
 
    
     There was no statistically significant difference in mean ejection fraction 
between the two groups. 
     The estimated mean left ventricular mass index was higher in alcoholics which 
was statistically significant (p<0.001). 
 
 
Table 6 :  POSTERIOR WALL THICKNESS & INTERVENTRICULAR 
SEPTAL THICKNESS 
 
  Range Mean Std. Deviation 
 
PWTd (cm) 
Controls 0.7 – 1.2 0.89 0.10 
p = 0.000 Group 1 0.7 – 1.1 0.86 0.11 
Group 2 0.8 - 1 0.92 0.08 
Group 3 0.9 – 1.2 1.06 0.09 
IVSTd (cm) 
Controls 0.7 – 1.2 0.93 0.12 
p = 0.128 Group 1 0.8 – 1.2 0.98 0.11 
Group 2 0.8 – 1.1 0.98 0.10 
Group 3 0.7 – 1.2 1.00 0.13 
 
       The posterior wall thickness in diastole (p<0.001) showed a significant 
increase in alcoholics. 
        
 
 
 
 
 
DOPPLER LEFT VENTRICULAR DIASTOLIC FILLING VARIABLES 
 
Table 7 : ISOVOLUMIC RELAXATION TIME & DECELERATION TIME 
 
  Range Mean Std. Deviation 
 
IVRT (ms) 
Controls 63 - 127 85.04 13.33 
p = 0.000 Group 1 70 - 93 76.72 5.21 
Group 2 74 - 100 87.11 6.44 
Group 3 75 - 120 96.98 12.74 
DT (ms) 
Controls 113 - 220 160.36 24.25 
p = 0.000 Group 1 132 - 185 153.41 15.35 
Group 2 142 - 196 171.63 15.40 
Group 3 172 - 226 198.42 15.70 
 
    The isovolumic relaxation time and the deceleration time of the early transmitral 
flow velocity was significantly prolonged in alcoholics compared to controls 
(p<0.001).  
 
 
 
 
 Table 8 : E, A & E/A 
 
  Range Mean Std. Deviation 
 
E  (m/s) 
Controls 0.63 – 1.12 0.85 0.12 
p = 0.132 Group 1 0.53 – 1.02 0.83 0.16 
Group 2 0.60 – 1.03 0.80 0.13 
Group 3 0.50 – 1.03 0.76 0.16 
A  (m/s) 
Controls 0.40 – 0.90 0.67 0.13 
p = 0.000 Group 1 0.40 – 0.91 0.61 0.15 
Group 2 0.52 – 0.92 0.70 0.12 
Group 3 0.50 – 1.12 0.87 0.17 
E/A 
Controls 0.79 – 1.92 1.30 0.29 
p = 0.000 Group 1 1.09 – 1.68 1.37 0.17 
Group 2 0.92 – 1.38 1.15 0.14 
Group 3 0.67 – 1.22 0.89 0.18 
 
       The peak early transmitral flow velocity (E) did not show a statistically 
significant difference among alcoholics and controls. The peak late transmitral 
flow velocity (A) was higher in alcoholics (p<0.001). E/A ratio was significantly 
lower in alcoholics (p<0.001) compared to controls. 
CORRELATION WITH DURATION OF ALCOHOLISM 
 
      Stepwise multiple linear regression analysis was used to evaluate the effects of 
several independent variables (age, pulse rate, blood pressure, duration of 
alcoholism, quantity of ethanol consumption) on the echocardiographic 
parameters, each of which was considered separately as a dependent variable. 
 
      The left ventricular end diastolic volume index (p=0.000), LV mass index 
(p=0.000), posterior wall thickness (p=0.000), isovolumic relaxation time 
(p=0.002), deceleration time (p=0.020) and  A (p=0.012) were significantly related 
to the duration of alcohol consumption.  
 
        The ejection fraction and interventricular septal thickness were not affected 
by any of the variables mentioned above. 
 
EARLIEST CHANGE 
 
     The earliest abnormality that occurred was detected by comparing the three 
alcoholic groups individually with controls by t-test. 
 
 Table 9 : Comparison between the means of  individual alcohol groups and 
controls 
PARAMETER GROUP 1 GROUP 2 GROUP 3 
EDVI p = 0.793 p = 0.003* p = 0.000* 
ESVI p = 0.824 p = 0.802 p = 0.563 
EF p = 0.790 p = 0.291 p = 0.476 
LVMI p = 0.807 p = 0.023* p = 0.000* 
PWT p = 0.170 p = 0.349 p = 0.000* 
IVST p = 0.178 p = 0.112 p = 0.061 
IVRT p = 0.632 p = 0.012* p = 0.008* 
DT p = 0.261 p = 0.031* p = 0.000* 
E p = 0.509 p = 0.220 p = 0.132 
A p = 0.097 p = 0.244 p = 0.000* 
E/A p = 0.397 p = 0.021 p = 0.000* 
 
       * p < 0.05 
 
       There was no significant difference between group 1and controls. Comparison 
between group 2 and controls showed an increase in end diastolic volume index, 
left ventricular mass, deceleration time and isovolumic relaxation time. 
Comparison between group 3 and controls demonstrated a significant increase in 
posterior wall thickness & A; and a lower E/A ratio, in addition to the 
forementioned differences.  
 
  
 
 
 
 
 
 
 
Discussion 
  
DISCUSSION 
 
       Chronic alcohol consumption leads to dilated cardiomyopathy in the long run. 
However, before clinical symptoms appear, certain changes occur in the heart 
which can be detected by echocardiography. These changes may be reversible with 
early abstinence. Hence it is significant to detect such changes. Many studies have 
been done in this regard which have shown conflicting results. Thus, this study was 
undertaken with a view to detect the cardiac abnormalities in  chronic 
asymptomatic alcoholics. 
 
       50 alcoholics were included in this study after applying the selection criteria. 
They were divided into 3 groups based on the duration of drinking in order to 
assess any difference in left ventricular function relative to the duration of 
drinking. 50 normal individuals with similar baseline characteristics were included 
as controls. 
 
       The number of alcoholics in each group were : 
                         Group 1  -  18  (36%) 
                         Group 2  -  19  (38%) 
                         Group 3  -  13  (26%) 
PATIENT CHARACTERISITICS 
 
       The baseline characteristics like age, body surface area, pulse and blood 
pressure of the cases and controls were comparable.  
 
       The duration of alcohol consumption varied from 6 to 23 years. The mean 
ethanol consumption was  137.4 ± 41.84 grams per day. The mean ethanol 
consumption was highest (190 ±  38.08 grams) in the group with the longest 
duration of drinking. This can be attributed to the development of  tolerance. 
 
       The laboratory parameters showed no significant differences among controls 
and alcoholics except for liver function tests, where alcoholics showed a mild 
elevation in enzymes (gamma glutamyl transferase, aspartate & alanine 
aminotransferases) which could be due to chronic ethanol consumption. 
 
ECHOCARDIOGRAPHIC MEASUREMENTS 
 
       The following table summarizes the results of our study which is compared 
with a similar study by Lazarevic et al39. 
       Lazarevic et al assessed the left ventricular function in 89 chronic 
asymptomatic alcoholics. He had divided the alcoholics into 3 groups (short, 
intermediate and long) according to the duration of alcohol consumption. 
 
 
Our study Lazarevic et al 
Controls Group 1 Group 2 Group 3 Controls Short Intermed-iate Long 
Duration
(years) - 7.80 11.47 19.04 - 8 13 19 
Amount 
(grams) - 114.44 123.16 190 - 258 252 247 
EF 74.04 74.44 75.68 75.31 67 66 67 66 
EDVI 47.04 47.43 51.50 54.86 65 74 72 72 
ESVI 14.18 14.29 14.30 13.87 21 25 24 25 
LVMI 75.73 75.07 81.93 94.44 79 86 94 93 
PWTd 0.89 0.86 0.92 1.06 0.83 0.88 0.94 0.91 
IVSTd 0.93 0.98 0.98 1.00 0.89 0.86 0.90 0.91 
IVRT 85.04 76.72 87.11 96.98 83 90 93 92 
DT 160.36 153.41 171.63 198.42 170 167 185 188 
E 0.85 0.83 0.80 0.76 0.59 0.55 0.59 0.54 
A 0.67 0.61 0.70 0.87 0.43 0.42 0.47 0.53 
E/A 1.30 1.37 1.15 0.89 1.40 1.36 1.31 1.08 
 
The data are presented as mean values. 
        The left ventricular systolic function and chamber dimensions were assessed 
using 2-D and M-mode echocardiography. 
 
       Our study found no statistically significant difference in ejection fraction 
between controls and alcoholics which is similar to the observations made by 
Lazarevic et al39 and Askanas et al48. 
 
       A significant increase in the end diastolic volume index in alcoholics 
compared to controls was observed in this study. There was no significant 
difference in end systolic volume index. However, Lazarevic et al39 reported 
increased left ventricular systolic and diastolic dimensions. The normal end 
systolic volume index in our study may be explained by Frank Starling’s law. An 
increase in end diastolic volume leads to increased contractility of the heart 
resulting in an increased stroke volume and reduced end systolic volume. The 
increased LV chamber volumes have been validated in animal studies by Shann D 
Kim et al51 (in rodents) and by Nancy Morris et al52 (in chickens). 
 
       The left ventricular mass index and posterior wall thickness was increased in 
alcoholics in this study. Interventricular septal thickness did not show a significant 
difference. This was similar to the observations made by AM Lazarevic et al39 , 
Kupari et al19 and Mathews et al50.  
 
      The diastolic function was assessed using Doppler echocardiography. 
 
       Our study demonstrated a significant increase in isovolumic relaxation time, a 
prolonged deceleration time and a lower E/A ratio in alcoholics. An increase in 
peak late transmitral flow velocity (A) was also observed. These observations 
imply impaired left ventricular relaxation or mild diastolic dysfunction. 
 
       A similar observation was stated by Lazarevic et al39. It has also been reported 
in studies by Kupari et al19 and De Castro et al53. The delayed relaxation may be 
due to a delay in inactivation of actin myosin interaction because of impaired 
transport of calcium ions from sarcoplasma into the sarcoplasmic reticulum (Noren 
et al54). In addition, associated ventricular dilatation or myocardial hypertrophy 
may be responsible for delayed relaxation55. 
 
 
 
 
CORRELATION WITH THE DURATION OF ALCOHOLISM 
 
              The data of this study was analysed to assess the correlation between the 
echocardiographic changes and independent variables like age, pulse rate, blood 
pressure, duration of drinking and amount of alcohol consumed. The 
echocardiographic parameters showed a significant correlation with the duration of 
drinking. The end diastolic volume index, left ventricular mass index, posterior 
wall thickness, isovolumic relaxation time, deceleration time and peak late 
transmitral flow velocity demonstrated a significant increase as the duration of 
alcohol consumption increased.   
 
       Only a few studies have been done in this regard. Lazarevic et al39 reported 
that alcoholics with a longer duration of drinking showed a longer deceleration 
time, higher A and reduced E/A. Kupari et al35 observed that the posterior wall 
thickness was weakly related to the duration of heavy drinking. However, the LV 
hypertrophy and dysfunction were poorly related to the duration and severity of 
alcohol consumption. These discrepancies may be explained by the differences in 
duration and amount of alcohol consumed. 
  
 
EARLIEST DETECTABLE CHANGE 
 
       In order to assess the earliest detectable change by echocardiography, the 
echocardiographic parameters among the three alcoholic groups and controls were 
individually compared. 
 
       The group with the shortest duration of drinking (group 1) did not show any 
significant difference as compared to controls. The difference between group 2 and 
controls was significant for end diastolic volume index, LV mass index, 
isovolumic relaxation time and deceleration time. Comparison between alcoholics 
with the longest drinking history (group 3) showed a significant increase in 
posterior wall thickness  and peak late transmitral flow velocity (A)and a decrease 
in E/A ratio apart from the differences as group 2 demonstrated. 
 
       This implies that the earliest change that occurred were an increased end 
diastolic volume and left ventricular mass which were then followed by 
development of impaired LV relaxation. 
 
       Lazarevic et al39 reported that LV volume changes occurred earlier which was 
followed by an increase in LV mass and later on impaired diastolic function.  
STUDY LIMITATIONS 
 
       Only male patients were selected due to rarity of female alcoholics in this part 
of the country. Hence, the observations made in this study are limited to males 
only. 
 
       The details of alcohol consumption as reported by the patients might be 
inaccurate as alcoholics tend to underestimate the quantity of alcohol consumed. 
 
       This study was performed in a cross sectional method. Hence, it cannot be 
conclusively said whether or not a chronic alcoholic would develop symptomatic 
diastolic dysfunction and later on systolic dysfunction if he/she continued to drink. 
This can be confirmed only by prospective studies. 
 
  
SUMMARY 
 
       This study was an observational study which assessed the left ventricular 
function in 50 chronic asymptomatic alcoholics attending Stanley Government 
Hospital. They were compared with age matched controls. The alcoholics were 
divided into 3 groups to assess the correlation between the observed parameters 
and duration of alcoholism. The following observations were made in alcoholics: 
 
 An increase in end diastolic volume index   (p < 0.001) 
 An increase in left ventricular mass index   (p < 0.001) 
 Increased posterior wall thickness   (p < 0.001) 
 Prolonged isovolumic relaxation time and deceleration time   (p < 0.001) 
 Increased peak late transmitral flow velocity (A)   (p < 0.001) 
 Reduced E/A ratio   (p < 0.001) 
 
       There was no significant differences in the end systolic volume index, ejection 
fraction, interventricular septal thickness and peak early transmitral flow velocity 
(E)   (p > 0.05). 
 
       The earliest change involved the left ventricular volume and mass which was 
then followed by changes in the Doppler parameters implying mild left ventricular 
diastolic dysfunction. The increase in end diastolic volume, LV mass, posterior 
wall thickness and diastolic filling variables were more remarkable in alcoholics 
with longer duration of alcohol consumption. 
 
  
 
 
 
 
 
 
 
Conclusions 
  
CONCLUSIONS 
 
 Preclinical cardiac abnormalities occur in chronic aymptomatic alcoholics 
which can be detected by echocardiography. 
 
 The alcoholics showed features of impaired left ventricular relaxation with 
preserved ejection fraction. 
 
 The changes observed in alcoholics by 2-D and M-mode echocardiography 
were increased left ventricular chamber volume in diastole, increased left 
ventricular mass and posterior wall thickness. 
 
 The abnormalities in Doppler parameters were prolonged isovolumic 
relaxation time and deceleration time; increased peak late transmitral flow 
velocity and reduced E/A ratio. 
 
 The earliest detectable change was an increase in LV chamber volume, mass 
and posterior wall thickness. This was then followed by impaired LV 
relaxation. 
 
 The increase in LV volume, mass, posterior wall thickness and alteration in 
diastolic parameters were significantly related to the duration of drinking. 
 
 The above findings can be considered as a marker for development of 
alcoholic cardiomyopathy but this cannot be validated unless longitudinal 
studies are carried out. 
 
 Further studies are required to demonstrate the course and progression of 
these abnormalities and their reversibility with early abstinence. 
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PROFORMA 
 
ASSESSMENT OF LEFT VENTRICULAR FUNCTION IN CHRONIC 
ASYMPTOMATIC ALCOHOLICS 
 
DEPARTMENT OF MEDICINE, SMCH 
 
 
NAME –                                                               IP / OP NO -                                                     
AGE –                                                                   DOA/DOD - 
GENDER – 
ADDRESS/CONTACT NO – 
 
 
HISTORY : 
 
SYMPTOMS – 
 
PAST HISTORY-  
 
 
 
 
 
 
 
 
DSM IV CRITERIA : 
 
Alcohol abuse  
Alcohol dependence  
 
SHT  PT  
DM  COPD/BA  
IHD  THYROID  
RHD  MEDICATIONS  
PERSONAL HISTORY-  
 
 Details of alcohol consumption : 
 
Duration  
Frequency  
Amount  
 
 Smoker       -        Y  /  N                            
 
O/E :    PR –                                  Height -                               RS - 
          
             BP -                                   Weight -                              CVS - 
 
                                                        BSA   -                                P/A- 
 
 
INVESTIGATIONS :                                                          
 
*  CBC                                                 *   FBS , PPBS                                             
 
 
*  RFT                                                 *  F. LIPID PROFILE 
 
 
*  LFT                                                  *  TFT 
 
 
*  ECG                                                  * CXR 
*  ECHO   :    2-D & M-mode measurements 
 
LVIDd (cm)  
EDV (ml) / EDVI  (ml/m2)  
ESV (ml) / ESVI  (ml/m2)  
FS  
EF  (%)  
PWTd  (cm)  
IVSTd  (cm)  
LVMI  (g/m2)  
 
 
                  Doppler LV diastolic filling variables 
 
 
IVRT  (ms)  
DT  (ms)  
E   (m/s)  
A   (m/s)  
E/A  
 
 
MASTER  CHART
S. NO. NAME AGE/SEX DURATION OF ALCOHOLISM AMOUNT OF ETHANOL SMOKER PR BP HEIGHT  WEIGHT BSA FBS/PPBS HB UREA/CREATININE AST/ALT
(years) (grams/day) (/min) (mm Hg) (cm) (kg) (m^2) (mg/dl) (g/dl) (mg/dl) (U/L)
1 SURESHKUMAR 28/M 6 100 YES 82 124/80 173 94 2.13 70 / 110 12 28/ 0.9 62 / 46
2 KARTHIKEYAN 34/M 11 120 NO 86 126/78 170 80 1.94 83 / 120 13.1 26 / 0.8 58 / 70
3 SUBAN SUBRAMANIAN 57/M 23 150 YES 76 130/82 160.9 78 1.87 76 / 124 13 25 / 0.8 74 / 67
4 RAMESH 46/M 15 130 NO 74 130/80 173 69 1.82 80 / 114 12.2 27 / 0.7 66 / 62
5 BALASUBRAMANIAN.B 38/M 10 110 YES 83 130/84 169 64 1.73 77 / 98 11.9 20 / 0.5 41 / 38
6 SELVAMANI.A 29/M 9 130 YES 79 120/78 172 73 1.87 85 / 117 13 22 / 0.6 42 / 40
7 SAGAYA PUSHPARAJ 45/M 15.5 180 NO 81 122/82 164 62 1.68 78 / 115 12.4 24 / 0.8 92 / 54
8 STEPHEN.S 24/M 7 160 YES 90 120/80 169 75 1.88 70 / 120 12.7 20 / 0.6 76 / 40
9 SURESH.R 45/M 18 200 YES 93 132/84 166 66 1.74 77 / 122 14 21 / 0.8 80 / 68
10 MANOHARAN.D 32/M 8 180 NO 89 120/70 174 85 2.03 84 / 99 12.9 18 / 0.7 63 / 38
11 DHINAKARAN.M 29/M 8 160 YES 77 130/70 167 52 1.55 89 / 118 12.4 24 / 0.9 54 / 43
12 RAJA.S 38/M 12 180 NO 72 132/80 152 54 1.51 75 / 110 11.6 28 / 1 60 / 42
13 HIREN N.DESAI 57/M 20 240 NO 84 118/70 176 115 2.37 104 / 124 12.5 28 / 0.9 100 / 78
14 KRISHNAKUMAR 34/M 10 120 YES 86 114/80 165 65 1.73 100 / 118 12.8 24 / 1.1 35 / 28
15 RAJESH 47/M 22 240 YES 75 120/80 172 82 1.98 76 / 120 13.2 23 / 0.7 86 / 64
16 GOKUL 32/M 9 90 NO 87 116/70 167 73 1.84 74 / 113 14 24 / 0.7 28 / 36
17 VIJAYAKUMAR 42/M 11 120 NO 76 120/80 171 85 2.01 82 / 116 13.5 26 / 0.9 68 / 72
18 CHANDRAN 42/M 12 120 YES 90 130/88 157 80 1.87 85 / 125 12 26 / 0.6 60 / 81
19 PARAMASIVAM 58/M 21 200 NO 79 130/76 154 76 1.8 80 / 108 13.8 27 / 1.1 98 / 73
20 SANJEEVI KUMAR 40/M 12 120 NO 82 124/80 176 90 2.1 79 / 116 13 26 / 0.8 70 / 40
21 SUNDARRAJ 51/M 19 120 YES 85 114/70 181 86 2.08 100 / 124 12.4 25 / 0.5 65 / 38
22 MURUGAN 30/M 9 90 YES 82 120/80 163 45 1.43 74 / 98 12.8 21 / 0.7 43 / 35
23 BHARATHI 36/M 12 100 NO 75 110/70 161 45 1.42 70 / 118 12 20 / 0.7 84 / 74
24 KUMAR 37/M 11 150 YES 76 130/84 164 78 1.89 75 / 108 13 23/0.8 104 / 68
25 MURUGESAN 44/M 8.5 120 NO 84 130/80 160 70 1.76 94 / 134 12.4 27 / 0.6 58 / 43
26 KUMAR 44/M 6 90 YES 80 134/80 166 57 1.62 83 / 127 13.1 21 / 0.9 32 / 42
27 SIVAKUMAR 52/M 21 240 YES 81 120/70 170 89 2.05 83 / 132 12.9 16 / 0.8 122 / 85
28 PERUMAL 36/M 11 120 NO 93 120/84 170 72 1.84 78 / 120 12.5 18 / 0.7 82 / 75
29 MANIMARAN 29/M 8 120 YES 79 116/78 168 63 1.71 74 / 126 13.4 21 / 1 44 / 33
30 VIJAY 41/M 12 90 YES 86 110/70 162 60 1.64 78 / 110 11.9 22 / 0.9 66 / 71
31 SUJAN 43/M 9 100 NO 77 126/78 171 70 1.82 90 / 134 11.8 20 / 0.8 72 / 58
32 RAMESH 27/M 7 130 YES 68 130/82 153 60 1.6 88 / 128 12.3 17 / 0.6 60 / 40
33 ARUN 44/M 12 130 NO 90 116/70 160 63 1.67 89 / 137 12.6 19 / 0.8 52 / 38
34 SENGOTTUVEL 50/M 17 150 NO 83 120/70 165 70 1.79 83 / 125 12 15 / 0.6 94 / 74
35 ANAND 33/M 8 100 YES 75 126/78 172 71 1.84 74 / 120 11.7 23 / 0.8 26 / 35
36 JAIKUMAR 28/M 6 90 YES 77 134/80 169 69 1.8 74 / 118 13 24 / 1.1 54 / 60
37 ARUL 35/M 13 120 NO 85 128/78 158 65 1.69 72 / 105 12.7 21 / 0.6 55 / 72
38 KANNAPAN 42/M 16 160 NO 86 130/80 170 78 1.92 68 / 123 12.6 19 / 0.8 92 / 120
39 RAVI 42/M 8 100 YES 91 126/82 163 66 1.73 74 / 107 13 17 / 0.6 76 / 55
40 MANIGANDAN 37/M 12 120 YES 85 126/74 168 83 1.97 91 / 128 11.8 16 / 0.8 68 / 45
41 VIJAYKUMAR 51/M 19 200 YES 74 130/76 176 88 2.07 80 / 130 12.7 18 / 0.9 88 / 43
42 RAMAIYAH 50/M 17 210 NO 84 120/80 159 60 1.63 87 / 129 12.5 17 / 0.8 93 / 38
43 KASIRAJA 45/M 9 110 NO 73 120/78 171 75 1.89 94 / 130 12 22 / 1 45 / 32
44 RAMAJEYAM 40/M 10 120 NO 65 128/74 165 69 1.78 76 / 104 12.4 21 / 0.8 81 / 58
45 MUNISEKAR 38/M 11 120 YES 66 126/72 169 58 1.65 95 / 128 11.8 18 / 0.7 67 / 65
46 SENTHIL 34/M 8 100 NO 95 120/80 154 53 1.51 86 / 119 12.8 17 / 0.8 55 / 73
47 MURALI 27/M 7 90 NO 85 130/80 157 62 1.64 81 / 132 12 19 / 0.7 60 / 70
48 MUTHUKUMAR 37/M 11 130 NO 69 132/84 165 71 1.8  79 / 128 12.4 17 / 0.7 81 / 63
49 SIVABALAN 32/M 10 120 YES 72 124/74 172 74 1.88 78 / 130 12.7 19 / 0.6 73 / 54
50 MANI 47/M 19 180 YES 74 120/78 161 59 1.62 77 / 125 13.6 18 / 0.7 75 / 96
MASTER  CHART
S. NO. NAME AGE/SEX DURATION OF ALCOHOLISM AMOUNT OF ETHANOL SMOKER PR BP HEIGHT  WEIGHT BSA FBS/PPBS HB UREA/CREATININE AST/ALT
(years) (grams/day) (/min) (mm Hg) (cm) (kg) (m^2) (mg/dl) (g/dl) (mg/dl) (U/L)
51 MATHIVANAN 47/M NO 80 112/70 170 89 2.05 82 / 130 11.9 21 / 0.9 31 / 32
52 BALASUBRAMANIAM 53/M YES 88 130/80 171 70 1.82 77 / 102 12.4 18.6/1.1 26 / 26
53 SHEKAR 54/M YES 64 134/84 170 72 1.84 70 / 123 12.8 18 / 0.7 21 / 35
54 BASIL P.T 29/M NO 86 114/66 153 60 1.6 75 / 127 12.4 17 / 0.8  24 / 32
55 BASKER 44/M NO 71 122/86 168 63 1.71 76 / 124 12 19 / 1 32 / 36
56 KANAGARAJ 25/M NO 80 120/80 160 63 1.67 84 / 130 13.2 17 / 0.9 27 / 21
57 THANGAVEL 50/M YES 74 132/80 162 60 1.64 83 / 134 12.8 21 / 0.8 36 / 29
58 JAGADISH 29/M NO 81 120/70 172 68 1.8 70 / 129 13.1 19 / 0.9  26 / 25
59 SURESH 26/M NO 78 120/80 152 48 1.42 78 / 124 13.2 21 / 0.9 21 / 18
60 JEGANMOHAN 32/M YES 83 118/70 160 55 1.56 76 / 124 12.8 22 / 1.1 32 / 37
61 RAMESH 43/M YES 89 124/78 169 58 1.65 73 / 128 12.4 17 / 0.7 27 / 31
62 KATHIRAVEL 36/M NO 90 134/82 172 63 1.73 80 / 127 12.6 19 / 0.8 25 / 18
63 SRIRAMULU 29/M NO 80 132/80 163 57 1.61 84 / 124 12.8 21 / 0.9 28 / 32
64 VENKATESH 41/M YES 76 114/78 157 52 1.51 80 / 120 11.8 22 / 0.9 40 / 29
65 SUBBU 44/M YES 70 116/78 159 50 1.49 77 / 119 13.2 19 / 0.8 30 / 20
66 ALEX 55/M NO 66 120/70 163 60 1.65 79 / 134 13.4 19 / 0.9 34 / 27
67 DINESH 37/M NO 75 128/80 172 75 1.89 84 / 124 13 20 / 0.8 21 / 24
68 SUBBAIYAH 49/M YES 78 132/84 173 80 1.96 82 / 124 12  21 / 0.8 16 / 19
69 VENUGOPAL 52/M NO 87 130/74 169 70 1.81 72 / 116 12.6 22 / 08 27 / 18
70 SRIRAM 34/M NO 88 124/86 166 65 1.73 66 / 118 12.5 24 / 1 21 / 25
71 SUNDAR 26/M YES 82 126/74 164 59 1.64 65 / 104 12.8 21 / 0.8 29 / 34
72 MURUGAVEL 33/M NO 94 126/78 170 75 1.88 70 / 112 13 23 / 0.9 23 / 31
73 RAJKUMAR 42/M NO 80 122/84 169 65 1.75 74 / 128 13.1 23 / 1 28 / 24
74 VELU 49/M YES 86 128/84 172 79 1.94 78 / 134 12.9 22 / 0.9 29 / 31
75 VENKATAIYAH 37/M YES 78 120/82 168 73 1.85 80 / 126 12.8 18 / 0.9 35 / 38
76 DINESHKUMAR 28/M NO 68 124/74 158 60 1.62 84 / 124 12.7 19 / 0.7  26 / 31
77 SUBRAMANI 54/M NO 70 120/74 161 72 1.79 94 / 132 11.9 21 / 0.7 19 / 14
78 ARAVIND 40/M YES 74 118/80 155 62 1.63 77 / 118 12.1 20 / 0.9 18 / 25
79 BALAJI 31/M NO 76 110/78 165 73 1.83 78 / 125 12.4 19 / 0.8 23 / 27
80 MUKUNDAN 35/M YES 86 120/70 167 76 1.88 90 / 130 12.3 18 / 0.8 31 / 25
81 KARTHIK 45/M YES 82 120/78 158 70 1.75 92 / 128 12.6 17 / 0.9 29 / 34
82 DURAISAMY 50/M YES 84 130/78 173 80 1.96 75 / 120 12 16 / 0.6 24 / 32
83 KANAKARAJ 48/M YES 68 130/84 171 75 1.89 79 / 125 13  17 / 0.8 37 / 29
84 KANNAN 26/M NO 74 126/82 163 68 1.75 88 / 138 13.1 24 / 0.9 35 / 26
85 RAMAN 32/M NO 78 122/70 160 57 1.59 83 / 134 13.2 23 / 1.1 40 / 36
86 KUPPUSAMY 31/M YES 80 118/78 153 58 1.57 82 / 120 13.6 21 / 0.9 30 / 32 
87 BHOOPATHI 43/M NO 85 124/80 169 72 1.84 78 / 115 14 19 / 0.9 23 / 30
88 MURUGAN 47/M NO 82 126/76 164 80 1.91 76 / 109 12.9 18 / 0.7 25 / 29
89 SURESHKUMAR 38/M YES 88 112/64 170 77 1.91 69 / 110 13 17 / 0.9 28 / 31
90 JOHN 34/M YES 79 110/74 158 63 1.66 68 / 124 13.9 18 / 0.7 26 / 34
91 BHOOPALAN 29/M NO 75 120/84 162 71 1.79 75 / 126 13 19 / 1 18 / 21
92 ARISTO 30/M NO 68 124/72 159 68 1.73 77 / 123 12.7 19 / 0.8 18 / 11
93 SATHIYA 36/M NO 67 110/76 171 78 1.92 86 / 120 12 17 / 0.7 16 / 19
94 BABU 27/M YES 85 132/84 172 81 1.97 83 / 138 11.8 16 / 0.6 25 / 29
95 PAUL 51/M YES 86 118/82 179 88 2.09 74 / 129 13 21 / 0.9 18 / 23
96 RAMKUMAR 48/M NO 79 126/80 166 60 1.66 81 / 127 12.4  20 / 0.8 19 / 24
97 VENKATRAMAN 42/M YES 70 130/68 164 63 1.69 80 / 131 12.7 19 / 0.8 18 / 15
98 KRISHNAN 36/M NO 82 114/78 172 76 1.91 75 / 123 12.9 17 / 0.6 22 / 31
99 GOVINDASAMY 46/M YES 83 120/84 169 73 1.85 70 / 126 12.8 19 / 0.8 23 / 19
100 RAMASAMY 40/M YES 85 110/70 168 61 1.69 82 / 132 13.1 20 / 0.8 27 / 32
MASTER  CHART
GGT T.BILIRUBIN T.CHOLESTEROL TGL / LDL TSH ECG CXR LVID (d) EDVI ESVI FS EF PWT (d) IVST (d) LVMI IVRT DT E A E/A
(U/L) (mg/dl) (mg/dl) (mg/dl) (μIU/ml) (cm) (ml/m^2) (ml/m^2) (%) (%) (cm) (cm) (g/m^2) (ms) (ms) (m/s) (m/s)
48 1.1 164 120 / 65 0.98 WNL NAD 5 43.66 11.73 35 73 1 1.2 81.89 76 160 1 0.91 1.09
72 0.9 134 98 / 46 3.45 WNL NAD 4.9 56.19 13.4 50 87 0.9 1 84.7 86 182 0.9 0.65 1.38
93 0.7 178 112 / 78 2.98 WNL NAD 4.5 62.03 17.11 39 78 1.2 1 92.6 102 221 0.5 0.74 0.67
78 0.8 163 132 / 65 3.61 WNL NAD 4.4 61.53 15.93 35 72 1 1.1 86.93 90 196 0.7 0.59 1.18
64 1 127 88 / 43 1.02 WNL NAD 4.3 52.02 13.73 41 80 1 0.9 82.36 88 170 0.63 0.57 1.1
52 1.2 146 110 / 50 0.69 WNL NAD 4.2 42.78 15.6 46 84 1.1 1 78.29 70 163 0.94 0.62 1.51
79 0.9 128 99 / 60 1.39 WNL NAD 4.7 52.98 13.36 42 81 1 0.9 91.32 86 172 0.71 0.92 0.77
58 0.8 187 140 / 88 4.01 WNL NAD 4.2 40.95 12.23 43 81 0.9 1 67.66 72 176 1.02 0.74 1.37
86 0.6 156 112 / 58 2.58 WNL NAD 4.9 48.85 16.09 48 78 1 0.8 87.9 90 202 0.94 1.02 0.92
63 0.7 138 132 / 74 3.62 WNL NAD 4.5 44.33 14.28 34 71 0.9 0.9 65.43 82 140 0.98 0.58 1.68
71 1 129 120 / 80 3.87 WNL NAD 4 56.77 14.19 42 81 0.9 1 76.27 79 136 0.83 0.57 1.45
41 1 150 78 / 68 2.49 WNL NAD 4.5 60.92 15.89 41 80 0.8 1 87.96 80 163 0.82 0.74 1.1
104 0.9 170 110 / 60 1.58 WNL NAD 5.2 53.16 13.5 47 78 1.1 1.1 93.15 94 217 0.61 0.5 1.22
45 0.8 147 126 / 87 3.72 WNL NAD 4.4 46.82 15.02 45 77 0.8 1.1 79.63 83 143.5 0.91 0.67 1.36
87 0.8 181 134 / 78 1.09 WNL NAD 4.8 54.04 16.71 36 80 1 1.1 91.87 120 196 1.03 0.94 1.09
74 1 193 125 / 65 2.05 WNL NAD 4.2 44.56 12.17 52 84 0.8 1.1 69.46 81 174 0.58 0.49 1.18
66 1.1 139 128 / 67 2.78 WNL NAD 5 47.76 12.93 42 73 0.8 0.9 73.05 91 186 0.75 0.73 1.02
93 0.8 142 140 / 80 4.02 WNL NAD 4.8 47.59 15.5 45.2 77 0.9 1 84.93 74 189 0.66 0.72 0.92
48 0.9 138 136 / 76 4.22 WNL NAD 4.9 54.45 16.83 43.5 75 1.1 1 104.5 110 190 0.7 1.01 0.69
72 1 162 128 / 76 3.94 WNL NAD 4.8 49.52 13.33 39 70 0.9 1 75.63 100 180 0.69 0.54 1.27
83 0.9 170 125 / 79 2.46 WNL NAD 5.1 48.56 15.38 36 67 1 1.1 96.53 114.8 186.5 0.7 0.9 0.78
54 0.8 158 130 / 81 3.19 WNL NAD 4.4 48.95 18.18 24 65 0.9 0.8 82.5 76 138 0.53 0.44 1.2
58 0.9 148 115 / 72 2.56 WNL NAD 4.4 57.04 14.08 51 85 1 0.8 83.03 85 191 1.03 0.89 1.15
74 0.8 125 108 / 60 0.98 WNL NAD 4.5 46.03 12.69 43.8 75 1 1.1 86.76 87 150 0.9 0.7 1.28
81 0.5 163 129 / 64 1.68 WNL NAD 4.3 56.7 19.26 36 66 1 1 80.96 93 161 0.83 0.6 1.38
56 0.7 178 101 / 65 3.52 WNL NAD 4.5 40.12 14.19 41 72 0.7 0.8 64.5 77 153 0.6 0.4 1.5
81 0.9 145 119 / 59 2.58 WNL NAD 5 58.05 17.56 40 72 1 1.2 101.05 100 226 0.76 0.89 0.85
79 1.2 184 123 / 67 4.03 WNL NAD 4.4 50 14.67 36 81 0.8 1.1 74.87 86 172 0.8 0.74 1.08
67 1 174 129 / 83 3.86 WNL NAD 4.5 48.54 14.03 53 77 0.8 0.9 71.97 76 153 0.9 0.79 1.13
72 0.6 163 130 / 78 2.57 WNL NAD 4.6 53.04 15.24 33 69 0.9 0.9 73.67 94 180 0.83 0.68 1.22
83 0.8 156 127 / 70 2.94 WNL NAD 4.7 50.8 13.95 42 80 0.8 1.1 84.29 72 164 1.02 0.77 1.32
67 0.9 176 124 / 73 3.15 WNL NAD 4.2 47.68 13.13 47 74 0.7 0.9 63.3 74 147 0.75 0.47 1.59
86 0.7 144 112 / 64 0.99 WNL NAD 4.5 49.9 14.37 50 73 1 1 91.78 99 171 0.69 0.6 1.15
96 1 185 133 / 82 1.72 WNL NAD 4.7 52 15.64 37 85 1.1 0.8 85.7 75 192 0.81 0.72 1.13
62 1.1 182 135 / 79 2.95 WNL NAD 4.7 47.83 14.13 48 78 0.8 0.9 71.91 80 132 0.75 0.57 1.31
46 0.4 136 126 / 63 2.04 WNL NAD 5 43.89 13.33 41 73 0.7 0.9 75.44 73 139.5 0.83 0.58 1.43
61 0.9 129  132 / 70 1.65 WNL NAD 4.5 50.89 15.98 39 67 1 1 90.69 88 142 0.94 0.92 1.02
72 0.8 147 121 / 67 1.9 WNL NAD 4.9 51.04 14.58 40 69 1.1 1 97.96 82 188 0.54 0.68 0.79
53 1 183 142 / 89 3.74 WNL NAD 4.4 48.43 13.29 36 72 0.9 1.1 85.45 77 157 0.98 0.86 1.13
68 0.7 172 130 / 82 2.16 WNL NAD 5.1 47.72 14.72 44 75 0.9 1.1 95.43 93 179 0.75 0.77 0.97
79 0.8 189 129 / 73 0.86 WNL NAD 5.2 57.97 15.46 45 68 1.1 0.7 81.63 102 208 0.78 0.94 0.82
84 0.6 190 128 / 74 0.97 WNL NAD 4.9 54.6 15.33 38 73 0.9 1 100.2 94 185 0.93 0.89 1.04
75 0.7 157 125 / 65 1.58 WNL NAD 4.8 52.38 13.76 47 78 0.9 1 84.03 73 185 0.67 0.46 1.45
55 0.9 164 130 / 76 4.01 WNL NAD 4.5 48.54 15.17 41 81 1 0.9 80.27 81 176.5 0.83 0.86 0.96
64 1 178 127 / 76 2.47 WNL NAD 4.2 52.72 15.51 35 77 0.9 0.8 66.57 83 165 0.6 0.52 1.15
71 0.8 184 128 / 82 2.38 WNL NAD 4 50.33 13.24 29 78 0.8 1 72.64 74 147 0.74 0.54 1.37
63 0.6 166 123 / 74 3.42 WNL NAD 4.3 45.12 12.19 30 70 0.8 1 75.18 76 136 0.95 0.61 1.55
58 0.8 173 118 / 69 2.89 WNL NAD 4.5 51.94 14.45 42 68 0.9 1.1 85.15 85 158 0.77 0.59 1.3
67 0.7 168 113 / 61 1.73 WNL NAD 4.4 48.4 13.82 38 71 1 0.9 73.27 82 167 1.03 0.83 1.24
102 0.8 152 124 / 65 2.94 WNL NAD 4.2 65.43 18.51 43 75 1.2 1.1 103.36 96 198 0.86 1.12 0.76
MASTER  CHART
GGT T.BILIRUBIN T.CHOLESTEROL TGL / LDL TSH ECG CXR LVID (d) EDVI ESVI FS EF PWT (d) IVST (d) LVMI IVRT DT E A E/A
(U/L) (mg/dl) (mg/dl) (mg/dl) (μIU/ml) (cm) (ml/m^2) (ml/m^2) (%) (%) (cm) (cm) (g/m^2) (ms) (ms) (m/s) (m/s)
17 0.6 185 131 / 79 3.21 WNL NAD 4.6 47.32 12.68 41 72 1 1.2 88.4 127 220 0.86 0.7 1.23
36 0.6 149 132 / 77 1.07 WNL NAD 4.6 54.39 17.03 38 68 0.9 1 81.38 96 130 0.9 0.8 1.125
29 0.4 179 126 / 73 2.06 WNL NAD 4.7 57.07 14.67 43 74 1 1.1 101.92 84 200 0.8 0.9 0.89
38 1.1 157 123 / 75 3.68 WNL NAD 4.2 50.63 14.37 39 70 0.9 0.9 74.17 63 140 0.9 0.6 1.5
19 0.9 169 137 / 82 1.82 WNL NAD 4 42.69 12.68 38 68 0.9 1.1 69.4 90 127 1 0.8 1.25
17 1 150 132 / 74 2.97 WNL NAD 4 38.92 13.77 35 65 0.9 0.9 65.68 101 136 0.7 0.5 1.4
25 0.6 138 131 / 72 2.78 WNL NAD 4.4 54.88 15.24 41 72 0.9 1 84 76 160 1.1 0.8 1.375
27 0.8 142 127 / 68 3.25 WNL NAD 4.4 48.33 11.11 41 76 0.8 1 79.12 120 113 0.76 0.4 1.9
21 1.1 146 124 / 66 2.14 WNL NAD 4.3 52.82 16.9 40 79 0.9 0.9 86.83 74 150 0.96 0.8 1.2
33 0.9 157 134 / 68 2.76 WNL NAD 4.6 42.95 12.82 37 81 0.8 0.8 75.58 80 167 0.77 0.61 1.26
23 0.7 173 125 / 67 0.96 WNL NAD 4.5 46.06 13.33 42 74 0.9 1 86.59 74 145 0.86 0.53 1.62
27 0.9 179 119 / 70 1.49 WNL NAD 4.3 39.88 13.87 39 85 0.8 1.1 76.73 86 157 0.89 0.7 1.27
45 1 160 117 / 64 2.48 WNL NAD 4.1 44.72 15.53 37 65 1 0.9 76.38 73 163 1 0.58 1.72
34 0.5 154 132 / 71 3.21 WNL NAD 3.8 41.72 15.23 52 72 0.8 1 66.93 92 144 0.63 0.75 0.84
31 0.6 183 129 / 72 4.09 WNL NAD 4 47.65 12.75 44 82 0.9 0.8 68.08 101 170 0.86 0.74 1.16
23 0.9 157 121 / 61 3.65 WNL NAD 4.1 51.51 14.55 39 71 0.8 0.9 63.99 98 220 0.92 0.69 1.33
25 1 164 127 / 69 2.97 WNL NAD 4.5 44.44 14.29 40 70 0.7 1 65.12 81 140 0.65 0.72 0.9
35 0.8 171 128 / 63 2.43 WNL NAD 5.2 52.55 16.32 48 78 0.8 1.1 99.05 80 166 1.02 0.53 1.92
29 0.7 183 133 / 72 2.79 WNL NAD 4.7 50.28 15.46 39 67 0.9 0.8 73.11 70 183 0.97 0.64 1.51
37 0.6 186  139 / 82 3.98 WNL NAD 4.7 47.51 14.45 42 81 0.9 1 88.68 67 197 0.88 0.53 1.66
24 0.4 159 129 / 72 3.64 WNL NAD 4.2 47.56 15.85 41 70 0.9 0.8 66.97 88 130 0.78 0.65 1.2
18 1 161 134 / 65 3.01 WNL NAD 4.2 47.34 12.77 37 86 0.8 1 63.12 74 151 0.86 0.53 1.62
31 1.1 157 109 / 59 2.05 WNL NAD 4.3 53.71 15.43 38 72 1 0.9 75.85 75 146 0.92 0.5 1.84
25 0.7 153 118 / 64 2.38 WNL NAD 4.4 45.36 12.89 42 80 0.7 1.1 65.98 69 187 0.77 0.63 1.22
27 0.8 174 123 / 62 1.73 WNL NAD 4.1 55.68 16.76 29 78 0.9 0.9 61.69 72 134 0.65 0.72 0.9
35 1.2 187 114 / 67 1.9 WNL NAD 4 55.56 14.2 40 82 1.1 1 84.07 81 147 1.02 0.64 1.59
21 0.9 175 126 / 65 2.43 WNL NAD 4.6 48.6 11.73 35 76 0.8 0.9 71.31 85 153 0.93 0.87 1.06
17 0.6 168 142 / 83 2.09 WNL NAD 5.2 44.79 13.5 37 82 0.8 0.8 89.09 93 164 0.86 0.62 1.38
19 0.7 155 137 / 71 3.49 WNL NAD 5 39.35 13.11 41 80 1 0.8 86.45 100 170 0.9 0.71 1.27
14 1.1 163  129 / 69 3.12 WNL NAD 4.7 44.68 14.89 39 67 1 0.7 70.38 84 144 1 0.85 1.17
23 0.9 176 139 / 84 2.38 WNL NAD 4.7 40.57 18.86 40 72 0.8 0.9 75.61 75 140 0.7 0.52 1.35
16 0.8 182 129 / 58 2.34 WNL NAD 4.8 38.27 15.31 45 74 0.8 1.1 81.03 79 168 0.64 0.81 0.79
27 1 158 112 / 72 0.84 WNL NAD 4.4 42.86 13.76 50 77 0.9 1 72.89 80 180 0.69 0.53 1.3
36 0.6 175  134 / 78 1.27 WNL NAD 3.8 39.42 14.28 38 81 1.2 0.9 71.9 90 201 0.88 0.6 1.47
41 0.7 163 109 / 62 1.83 WNL NAD 4.2 60.38 13.83 42 70 0.8 1.1 80.38 92 183 0.97 0.62 1.56
37 0.8 173  108 / 62 2.04 WNL NAD 3.9 51.59 12.1 35 69 0.9 1 72.34 112 174 0.9 0.49 1.84
29 1.2 148 126 / 82 2.05 WNL NAD 4.1 41.3 12.5 41 71 0.8 0.9 57.38 74 162 0.87 0.55 1.58
32 1 187 132 / 66 3.72 WNL NAD 4 40.31 16.23 43 73 0.9 0.8 53.1 73 157 0.76 0.66 1.15
25 0.8 191  142 / 83 3.07 WNL NAD 4.8 34.55 13.61 38 65 1 0.8 77.37 83 154 0.84 0.89 0.94
22 0.6 153 108 / 53 1.96 WNL NAD 4.2 49.4 12.65 40 79 0.9 1 76.99 76 140 0.77 0.58 1.32
18 0.8 154 115 / 64 1.34 WNL NAD 4.5 43.58 11.17 37 80 0.8 0.8 63.48 79 166 0.75 0.82 0.91
15 0.7 167 127 / 76 1.28 WNL NAD 4.4 39.3 14.45 28 72 1 0.9 79.63 82 182 1.12 0.84 1.33
27 0.9 178 141 / 92 2.36 WNL NAD 4.7 52.08 14.58 45 75 1.1 0.7 74.33 86 196 0.81 0.77 1.05
31 0.6 162 135 / 81 2.15 WNL NAD 4.5 48.73 16.24 39 82 0.8 1 67.42 94 140 0.98 0.74 1.32
17 0.5 179 142 / 84 3.49 WNL NAD 4.4 54.07 15.31 41 77 0.9 1.1 70.73 96 155 0.71 0.65 1.09
28 1.1 157 128 / 78 3.02 WNL NAD 4.1 51.2 16.27 40 68 0.9 0.8 63.61 81 120 0.93 0.59 1.57
38 1 169  140 / 70 2.84 WNL NAD 4.8 43.2 13.61 37 72 0.8 0.9 81.11 74 138 0.76 0.54 1.4
33 0.4 158 130 / 72 2.75 WNL NAD 5 46.07 13.09 35 70 1 0.9 88.96 75 157 0.8 0.65 1.23
26 0.7 147 108 / 68 2.1 WNL NAD 4.5 49.19 11.89 42 64 1.1 0.7 71.79 107 181 0.83 0.88 0.94
43 0.8 151 112 / 70 3.02 WNL NAD 4.6 46.75 11.24 36 68 0.9 1 100.5 90 170 0.75 0.83 0.9

 
 
 
 
 
 
Figure 1 : M – mode echocardiography at the level of the mitral valve 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 : 2 - D image of the heart, parasternal long axis view 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 : Diastolic filling patterns 
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